search for


Effects of Hovenia dulcis var. Koreana Extracts in Osteoclast Differentiation
YAKHAK HOEJI 2018;62(6):388-393
Published online December 30, 2018
© 2018 The Pharmaceutical Society of Korea.

Kwang-Jin Kim*, Yongjin Lee*, Kyung-Yun Kang**, Sung-Tae Yee*, Sang-Jip Nam***,Mi-Kyung Lee****, Mi-Ja Lee*****, and Young-Jin Son*,#

*Department of Pharmacy, Sunchon National University, Jeonnam, 57922, Republic of Korea **Suncheon Research Center for Natural Medicines, Jeonnam, 57922, Republic of Korea ***Department of Chemistry and Nano Science, Global Top 5 Program, Ewha Womans University, Seoul 03760, Republic of Korea ****Department of Food and Nutrition, Sunchon National University, Jeonnam, 57922, Republic of Korea *****Rural Development Administration, National Institute of Crop Science, Jeonbuk, 55365, Republic of Korea
Correspondence to: Young-Jin Son Department of Pharmacy, Sunchon National University, Jeonnam, 57922, Republic of Korea Tel.: +82-61-750-3755 Fax.: +82-61-750-3028 E-mail:
Received October 1, 2018; Revised November 7, 2018; Accepted November 23, 2018.
Osteoporosis is a disease characterized by a decrease in bone mineral density and an increase in fracture rate. One of the most related to bone density in osteoporosis is osteoclast. Osteoclasts, the only cells that resorbing bone, are a key mediator of skeletal disease such as osteoporosis. Therefore, one of the most influential methods for treating bone diseases with reduced bone mass is inhibiting osteoclast formation and activation. In previous studies, we reported that Hov-enia dulcis var. Koreana extracts (HD) inhibits osteoclast differentiation and is effective in the prevention of osteoporosis in vivo. However, we did not disclose how HD works during osteoclast differentiation. Herein, we investigated the mechanisms of anti-osteoclastogenic activity of HD on osteoclast differentiation in vitro. HD inhibited RANKL-mediated osteoclast differentiation of cultured BMMs in a dose-dependent manner and did not exert a cytotoxic effect on BMMs. HD suppressed transcriptional and translational expression of NFATc1 as well as osteoclast-related genes such as TRAP, DCSTAMP, and cathepsin K in BMMs treated with RANKL. Taken together, these results suggest that HD may influence the expression levels of NFATc1 and osteoclast-specific genes during osteoclast differentiation. Therefore, HD may be usefully used as a functional food or a therapeutic agent for bone diseases such as osteoporosis.
Keywords : bone, osteoporosis, osteoclast, RANKL, NFATc1, Hovenia dulcis

June 2019, 63 (3)
Full Text(PDF) Free

Social Network Service

Cited By Articles
  • CrossRef (0)